MetaVia Inc. (MTVA) stock
MTVANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.30+0.00 (0.00%)
Close on Nov 13, 2026Market cap $8.56MP/E –Yield –
MetaVia enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
MetaVia's enterprise value was -$3.17M on Nov 11, 2026, against $4.56M a year earlier. Over the last 5 years it ranged from -$18.93M to $20.21M, with a median of -$3.41M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$3.17M | -174.3% |
| 2025 | Dec 31, 2025 | $4.26M | – |
| 2024 | Dec 31, 2024 | -$4.19M | – |
| 2023 | Dec 29, 2023 | -$8.08M | – |
| 2022 | Dec 30, 2022 | -$5.72M | -128.3% |
| 2021 | Dec 31, 2021 | $20.21M | -72.7% |
| 2020 | Dec 31, 2020 | $73.89M | +181.9% |
| 2019 | Dec 31, 2019 | $26.21M | -67.7% |
| 2018 | Dec 31, 2018 | $81.24M | -89.1% |
| 2017 | Dec 29, 2017 | $742.97M | +17.5% |
| 2016 | Dec 30, 2016 | $632.46M | – |
See a number that looks wrong?